McLeod neuroacanthocytosis: Genotype and phenotype

Annals of Neurology

Volumn 50, Issue 6, 2001, Pages 755-764

  Danek, Adrian ^a,n   Rubio, Justin P ^b   Rampoldi, Luca ^c   Ho, Mengfatt ^d   Dobson Stone, Carol ^e   Tison, François ^f   Symmans, William A ^g   Oechsner, Matthias ^h   Kalckreuth, Wolfgang ⁱ   Watt, Julie M ^j   Corbett, Alastair J ^k   Hamdalla, Hisham H M ^l   Marshall, Andrew G ^m   Sutton, Ian ^a   Dotti, Maria Teresa ^b   Malandrini, Alessandro ^c   Walker, Ruth H ^d   Daniels, Geoff ^e   Monaco, Anthony P ^f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d Medlab   (New Zealand)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f Zentrum fur Psychiatrie   (Germany)

^g AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^h Department of Microbiology and Infectious Diseases   (Australia)

ⁱ LEEDS GENERAL INFIRMARY   (United Kingdom)

^j WYTHENSHAWE HOSPITAL   (United Kingdom)

^k QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^l UNIVERSITY OF SIENA   (Italy)

^m VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ NHS BLOOD AND TRANSPLANT   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; PROTEIN; PROTEIN XK; UNCLASSIFIED DRUG;

ACANTHOCYTOSIS; ADULT; AGED; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DNA SEQUENCE; GENE MUTATION; GENOTYPE; HUMAN; MALE; MYOPATHY; NEUROACANTHOCYTOSIS; PATHOGENESIS; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; AGING; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; CARRIER PROTEINS; CHOREATIC DISORDERS; HUMANS; KELL BLOOD-GROUP SYSTEM; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PHENOTYPE;

EID: 0035202829     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10035     Document Type: Article

References (67)

1. A new phenotype (McLeod) in the Kell blood-group system
2. Haematological changes associated with the McLeod phenotype of the Kell blood group system
3. Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system
4. The Kell blood group, Kx antigen, and chronic granulomatous disease
5. Elevated serum creatine phosphokinase in subjects with McLeod syndrome
6. "New" clinical features of McLeod syndrome
7. Deleted antigens of the Rhesus and Kell blood groups: Association with cell membrane defects
8. Cardiomyopathy associated with the syndrome of amyotrophic chorea and acanthocytosis
9. Benign X-linked myopathy with acanthocytes (McLeod syndrome), its relationship to X-linked muscular dystrophy
10. Normal dystrophin in McLeod myopathy
11. McLeod syndrome: A distinct form of neuroacanthocytosis
12. A family of McLeod syndrome, masquerading as chorea-acanthocytosis
13. A novel frameshift mutation in the McLeod syndrome gene in a Japanese family
14. A case of McLeod syndrome with unusually severe myopathy
15. Unusual muscle pathology in McLeod syndrome
16. Muscle CT scan findings in McLeod syndrome and chorea-acanthocytosis
17. A novel mutation of the McLeod syndrome gene in a Japanese family
18. McLeod syndrome: A novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings
19. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein
20. Functional and structural aspects of the Kell blood group system
21. Analysis of deletions in three McLeod patients: Exclusion of the XS locus from the Xp21.1-Xp21.2 region
22. Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21
23. McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene
24. Atypical McLeod syndrome manifested as X-linked chorea-acanthocytosis, neuromyopathy and dilated cardiomyopathy: Report of a family
25. The chorea of McLeod syndrome
26. Acanthocytosis
27. Cerebral involvement in McLeod syndrome
28. Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis
29. Verapamil induces complete remission of the clinical and laboratory findings in a patient with chorea-acanthocytosis
30. Diagnostic tests for choreoacanthocytosis
31. Benign normolipoproteinaemic acanthocytosis
32. Neuroacanthocytosis: A clinical, haematological and pathological study of 19 cases
33. Anti-Km in a transfused man with McLeod syndrome
34. Acanthocytosis and haemolytic anaemia due to the McLeod blood group
35. Biochemical studies on McLeod phenotype erythrocytes
36. An individual with McLeod syndrome and the Kell blood group antigen K (K1)
37. McLeod syndrome (hemolysis, acanthocytosis, and increased serum creatine kinase): Potential confusion with polymyositis
38. Unusual presentation of a McLeod individual
39. McLeod-Neuroakanthozytose: Ein zu selten diagnostiziertes Syndrom?
40. A case of McLeod syndrome
41. First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease
42. Kell phenotypes in chronic granulomatous disease: A potential transfusion hazard
43. Chronic granulomatous disease and McLeod syndrome in a black child
44. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome
45. Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype
46. Malattia granulomatosa cronica e fenotipo McLeod. Descrizione di un caso
47. The first example of the McLeod phenotype in a Japanese baby with chronic granulomatous disease
48. Successful interferon gamma therapy in a patient with X-linked chronic granulomatous disease, McLeod syndrome and hyper-IgE
49. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy
50. A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis
51. Patients with features similar to Huntington's disease, without CAG expansion in huntingtin
52. A conserved sorting-associated protein is mutant in chorea-acanthocytosis
53. The gene encoding a newly discovered protein, chorein, is mutated in choreaacanthocytosis
54. Proteolytic processing of big endothelin-3 by the Kell blood group protein
55. Expression of Kell blood group protein in nonerythroid tissues
56. Endothelin and dopamine release
57. Intracellular assembly of Kell and XK blood group proteins
58. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells
59. Dystrophin expression and genotypic analysis of two cases of benign X linked myopathy (McLeod's syndrome)
60. Localization of the McLeod locus (XK) within Xp21 by deletion analysis
61. Neuropathology of McLeod phenotype is like choreaacanthocytosis (CA)
62. Morphology and physiology of the McLeod erythrocyte
63. Structural and biochemical analysis of the McLeod erythrocyte membrane
64. A suggested nomenclature for designating mutations
65. Analysis of the McLeod syndrome gene in three patients with neuroacanthocytosis